Laos PDR, Malawi, Rwanda, and Zambia have received oral antiviral treatments for high-risk patients through COVID Treatment Quick Start Consortium
The COVID Treatment Quick Start Consortium announced that the governments of Zambia, Laos, Malawi and Rwanda have received shipments of PAXLOVID™, Pfizer’s COVID-19 oral treatment.
Read more
Request for proposals for the implementation of a Medical Gas Piping System (MGPS) in Clinique Universitaire de Kinshasa, DRC
The Clinton Health Access Initiative, (CHAI) is a sub-grantee of FHI360 on the Meeting Targets and Maintaining Epidemic Control (EpiC) project, a global five-year project funded by the U.S. Agency for International Development (USAID). EpiC receives COVID-19 funding to prevent, prepare for, respond to and bolster health systems to address COVID-19 and reduce cases of...
Read more
Annual Report 2021
CHAI's 2021 Annual Report is out now. In it, we recognize the incredible efforts of our staff during a difficult year.
Read more
Partnership to introduce COVID oral antivirals and national test-and-treat programs announced by new public-private consortium
New test-and-treat consortium to quickly provide Ministries of Health in 10 low- and middle-income countries with oral antiviral treatments to high-risk patients and scale up wider access through 2023.
Read moreLooking back two years later: South Africa’s response to the first two COVID-19 waves
CHAI South Africa has co-authored a series of articles published in the South African Medical Journal examining South Africa’s response to the COVID-19 pandemic during the first two waves. The publication includes six articles covering topics from governance to epidemiology to community-based interventions and recovery efforts.
Read more
With investments over the last two years, CHAI is working with governments to close the medical oxygen gap in over 25 countries
In May 2021, with US$20 million from Unitaid, CHAI and PATH announced a new program to procure and supply medical oxygen equipment, working in partnership with ministries of health in countries across Africa, and Asia.
Read moreA database of local vaccine manufacturing commitments and tech-transfers
The database offers insights into donor and political commitments and tech-transfers to increase local manufacturing capacity in low- and middle-income countries to respond to global Covid-19 vaccine inequity
Read moreFAQ: What you need to know about CHAI’s generic Paxlovid deal
CHAI announced agreements with leading generic manufacturers to make generic Paxlovid available to low- and middle income countries for under US$25 per treatment course.
Read morePress release: CHAI announces agreements with leading generic manufacturers to make affordable COVID-19 treatment available in low- and middle-income countries
New agreements will make generic Paxlovid available at under US$25 per treatment course.
Read more
Integrating early non-communicable disease screening and counseling with COVID-19 vaccinations in Cambodia
CHAI in partnership with Cambodia’s Preventable Medicine Department and the Provincial Health Department of Takeo and Kampong Chhnang Provinces, designed and implemented a pilot program to provide adults over 40 with diabetes and hypertension screening while they received their COVID-19 vaccinations.
Read more